| METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2026-10-08 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Northstar Rx LLC | Ohm Laboratories Inc. | 2026-08-27 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | Product name | Mayne Pharma | Sharp Corporation | 2026-08-24 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2026-08-18 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 2026-08-17 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets for oral use, CII Initial U.S. Approval: 1955 | Product name | Aurolife Pharma, LLC | JANSSEN PHARMACEUTICALS, INC. | 2026-08-13 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Golden State Medical Supply, Inc. | Granules Pharmaceuticals Inc. | 2026-08-11 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules CD, CII Initial U.S. Approval: 1955 | Product name | Lannett Company, LLC | 2026-07-31 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2026-07-17 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Capsules safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Capsules Methylphenidate Hydrochloride Extended-Release Capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Rhodes Pharmaceuticals LLC | Patheon Manufacturing Services LLC | Knoa Pharmaceuticals LLC | 2026-05-29 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Capsules safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Capsules Methylphenidate Hydrochloride Extended-Release Capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Rhodes Pharmaceuticals LLC | Patheon Manufacturing Services LLC | Knoa Pharmaceuticals LLC | 2026-05-29 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Lannett Company, Inc. | 2026-05-28 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals of New York, LLC | 2026-05-27 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION, CII Initial U.S. Approval: 1955 | Product name | KVK-Tech, Inc. | ABHAI, LLC. | 2026-05-11 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Lannett Company, Inc. | 2026-05-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Actavis Pharma, Inc. | 2026-04-30 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 2026-04-29 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 2026-04-24 |
| These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | Product name | Trigen Laboratories, LLC | 2026-04-24 |
| METHYLPHENIDATE hydrochloride extended-release tablets USP. These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | Product name | Golden State Medical Supply, Inc. | Osmotica Pharmaceutical US LLC | 2026-04-23 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Golden State Medical Supply, Inc. | Granules Pharmaceuticals Inc. | 2026-04-23 |
| These highlights do not include all the information needed to use CONCERTA safely and effectively. See full prescribing information for CONCERTA. CONCERTA ® (methylphenidate hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Janssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Janssen Ortho LLC | Janssen-Cilag Manufacturing, LLC | 2026-04-20 |
| These highlights do not include all the information needed to use QUILLICHEW ER ® safely and effectively. See full prescribing information for QUILLICHEW ER ® . QUILLICHEW ER ® (methylphenidate hydrochloride) extended-release chewable tablets , for oral use, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2026-04-08 |
| These highlights do not include all the information needed to use QUILLICHEW ER ® safely and effectively. See full prescribing information for QUILLICHEW ER ® . QUILLICHEW ER ® (methylphenidate hydrochloride) extended-release chewable tablets , for oral use, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2026-04-08 |
| These highlights do not include all the information needed to use QUILLICHEW ER ® safely and effectively. See full prescribing information for QUILLICHEW ER ® . QUILLICHEW ER ® (methylphenidate hydrochloride) extended-release chewable tablets , for oral use, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2026-04-08 |
| These highlights do not include all the information needed to use QUILLICHEW ER ® safely and effectively. See full prescribing information for QUILLICHEW ER ® . QUILLICHEW ER ® (methylphenidate hydrochloride) extended-release chewable tablets , for oral use, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2026-04-07 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Northstar Rx LLC | Ohm Laboratories Inc. | 2026-04-02 |
| These highlights do not include all the information needed to use QUILLIVANT XR ® safely and effectively. See full prescribing information for QUILLIVANT XR ® . QUILLIVANT XR ® (methylphenidate hydrochloride) for extended-release oral suspension, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2026-03-24 |
| These highlights do not include all the information needed to use QUILLIVANT XR ® safely and effectively. See full prescribing information for QUILLIVANT XR ® . QUILLIVANT XR ® (methylphenidate hydrochloride) for extended-release oral suspension, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2026-03-20 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2026-03-17 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | Product name | Bryant Ranch Prepack | 2026-03-17 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | Product name | Bryant Ranch Prepack | 2026-03-17 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 2026-03-13 |
| These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 1955 | Product name | Neos Therapeutics Brands, LLC | Aphena Pharma Solutions | Halo Pharmaceuticals, Inc. | 2026-03-02 |
| These highlights do not include all the information needed to use CONCERTA safely and effectively. See full prescribing information for CONCERTA. CONCERTA ® (methylphenidate hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Janssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Janssen Ortho LLC | Janssen-Cilag Manufacturing, LLC | 2026-02-27 |
| These highlights do not include all the information needed to use QUILLICHEW ER ® safely and effectively. See full prescribing information for QUILLICHEW ER ® . QUILLICHEW ER ® (methylphenidate hydrochloride) extended-release chewable tablets , for oral use, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2026-02-25 |
| These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use, CII Initial U.S. Approval: 2000 | Product name | Trigen Laboratories, LLC | 2026-02-16 |
| Methylphenidate Hydrochloride Extended-Release Tablets, USP CII Rx Only These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. Initial U.S. Approval: 2000 | Product name | AvPAK | 2026-01-08 |
| Methylphenidate Hydrochloride Tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. Initial U.S. Approval: 1955 | Product name | AvPAK | 2026-01-08 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE hydrochloride extended-release tablets, USP for oral use CII Initial U.S. Approval: 2000 | Product name | Lannett Company, Inc. | 2026-01-06 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Tablets USP CII safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Tablets USP CII. Methylphenidate hydrochloride tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | KVK-TECH, INC. | Abhai, LLC | 2026-01-02 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | American Health Packaging | 2025-12-04 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HCl extended-release capsules, CII Initial U.S. Approval: 1955 | Product name | SpecGx LLC | 2025-12-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION, CII Initial U.S. Approval: 1955 | Product name | KVK-Tech, Inc. | ABHAI, LLC. | 2025-11-24 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Tablets USP CII safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Tablets USP CII. Methylphenidate hydrochloride tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | KVK-TECH, INC. | ABHAI, LLC | 2025-11-24 |
| These highlights do not include all the information needed to use METADATE CD ® safely and effectively. See full prescribing information for METADATE CD. METADATE CD (methylphenidate hydrochloride) extended-release capsules, CII Initial U.S. Approval: 1955 | Product name | Aytu BioPharma, Inc. | 2025-11-18 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2025-11-11 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | Product name | Mayne Pharma | Sharp Corporation | 2025-11-06 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Actavis Pharma, Inc. | 2025-10-31 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | American Health Packaging | 2025-10-22 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2025-10-14 |
| These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use CII Initial U.S. Approval: 2000 | Product name | Trigen Laboratories, LLC | 2025-10-14 |
| METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2025-10-08 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | SpecGx LLC | 2025-10-08 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HCl extended-release tablets, for oral use CII Initial U.S. Approval: 2000 | Product name | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | 2025-10-07 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals of New York, LLC | 2025-10-07 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Tablets USP CII safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Tablets USP CII. Methylphenidate hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | KVK-Tech, Inc. | ABHAI LLC | 2025-10-07 |
| These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. METHYLPHENIDATE transdermal system Initial U.S. Approval: 2006 | Product name | Mylan Pharmaceuticals Inc. | 2025-10-07 |
| These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. METHYLPHENIDATE transdermal system Initial U.S. Approval: 2006 | Product name | Mylan Pharmaceuticals Inc. | 2025-10-07 |
| These highlights do not include all the information needed to use JORNAY PM® safely and effectively. See full prescribing information for JORNAY PM. JORNAY PM (methylphenidate hydrochloride) extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Ironshore Pharmaceuticals Inc. | Patheon Puerto Rico, Inc. | 2025-10-03 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Capsules safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Capsules Methylphenidate Hydrochloride Extended-Release Capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Rhodes Pharmaceuticals | Patheon Manufacturing Services LLC | Purdue Pharmaceuticals L.P. | 2025-10-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | Product name | Dr. Reddy's Laboratories Inc | 2025-09-30 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules CD, CII Initial U.S. Approval: 1955 | Product name | Lannett Company, Inc. | 2025-09-30 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules CD, CII Initial U.S. Approval: 1955 | Product name | Lannett Company, Inc. | 2025-09-30 |
| These highlights do not include all the information needed to use QUILLIVANT XR ® safely and effectively. See full prescribing information for QUILLIVANT XR ® . QUILLIVANT XR ® (methylphenidate hydrochloride) for extended-release oral suspension, CII Initial U.S. Approval: 1955 | Product name | NextWave Pharmaceuticals, Inc | 2025-09-30 |
| These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets safely and effectively. See full prescribing information for methylphenidate hydrochloride extended-release tablets. Methylphenidate hydrochloride extended-release tablets for oral use, CII Initial U.S. Approval: 2000 | Product name | Trigen Laboratories, LLC | 2025-09-26 |
| These highlights do not include all the information needed to use RELEXXII ® safely and effectively. See full prescribing information for RELEXXII ® . RELEXXII ® (methylphenidate hydrochloride extended-release tablets) for oral use, CII Initial U.S. Approval: 2000 | Product name | Vertical Pharmaceuticals, LLC | 2025-09-26 |
| These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. Methylphenidate Transdermal System, CII Initial U.S. Approval: 2006 | Product name | PADAGIS US LLC | NOVEN PHARMACEUTICALS, INC. | 2025-09-25 |
| These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 1955 | Product name | Neos Therapeutics Brands, LLC | Aphena Pharma Solutions | Halo Pharmaceuticals, Inc. | 2025-09-24 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 1955 | Product name | Sandoz Inc | 2025-09-23 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 1955 | Product name | Sandoz Inc | 2025-09-23 |
| These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA ® (methylphenidate hydrochloride) extended-release capsules for oral use, CII Initial U.S. Approval: 1955 | Product name | Novartis Pharmaceuticals Corporation | 2025-09-23 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. Methylphenidate hydrochloride tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Solco Healthcare US,LLC | Prinston Pharmaceutical Inc. | Generics Bidco ⅡLLC | 2025-09-18 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | Product name | Mayne Pharma | Sharp Corporation | 2025-09-04 |
| These highlights do not include all the information needed to use DAYTRANA ® safely and effectively. See full prescribing information for DAYTRANA. DAYTRANA ® (methylphenidate transdermal system), CII Initial U.S. Approval: 2006 | Product name | Noven Therapeutics, LLC | Noven Pharmaceuticals, Inc. | 2025-09-01 |
| These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 1955 | Product name | Neos Therapeutics Brands, LLC | Aphena Pharma Solutions | Halo Pharmaceuticals, Inc. | 2025-08-21 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Camber Pharmaceutical Inc | Ascent pharmaceutical Inc | 2025-08-06 |
| Methylphenidate hydrochloride extended-release tablets, USP These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2025-07-15 |
| Methlyphenidate Hydrochloride Tablets, USP CII These highlights do not include all the information needed to use Methlyphenidate Hydrochloride Tablet safely and effectively. See full prescribing information for Methlyphenidate Hydrochloride Tablet. Initial U.S. Approval: 1955 | Product name | Aurolife Pharma, LLC | JANSSEN PHARMACEUTICALS, INC. | 2025-06-03 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2025-04-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2025-03-17 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE Chewable Tablets s afely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE Chewable Tablets . METHYLPHENIDATE HYDROCHLORIDE Chewable Tablets (Methylphenidate hydrochloride), for oral use, CII Initial U.S. Approval: 1955 | Product name | Rising Pharma Holdings, Inc. | Tedor Pharma Inc. | 2025-03-12 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Sun Pharmaceutical Industries, Inc. | Ohm Laboratories Inc. | 2025-02-27 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Amneal Pharmaceuticals of New York LLC | Amneal Pharmaceuticals of New York, LLC | Johnson Matthey Inc. | 2025-02-19 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Neolpharma, Inc. | 2025-02-12 |
| These highlights do not include all the information needed to use RITALIN safely and effectively. See full prescribing information for RITALIN. RITALIN ® (methylphenidate hydrochloride) tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Novartis Pharmaceuticals Corporation | 2025-02-05 |
| These highlights do not include all the information needed to use RITALIN safely and effectively. See full prescribing information for RITALIN. RITALIN ® (methylphenidate hydrochloride) tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Sandoz Inc | 2025-02-05 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION . METHYLPHENIDATE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1955 | Product name | Cranbury Pharmaceuticals, LLC | 2025-01-30 |
| These highlights do not include all the information needed to use METHYLPHENIDATE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for METHYLPHENIDATE TRANSDERMAL SYSTEM. METHYLPHENIDATE transdermal system Initial U.S. Approval: 2006 | Product name | Mylan Pharmaceuticals Inc. | 2025-01-27 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Northstar Rx LLC | Ohm Laboratories Inc. | 2025-01-20 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA) safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (LA). METHYLPHENIDATE HYDROCHLORIDE extended-release capsules (LA) for oral use, CII Initial U.S. Approval: 1955 | Product name | Dr. Reddy's Laboratories Inc | 2024-12-05 |
| METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CII Initial U.S. Approval: 1955 | Product name | Granules Pharmaceuticals Inc. | 2024-12-04 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-11-18 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-11-18 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-11-18 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-10-31 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS and METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS and METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | American Health Packaging | 2024-10-08 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | SpecGx LLC | 2024-09-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | SpecGx LLC | 2024-09-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Ascend Laboratories, LLC | Alkem Laboratories Limited | 2024-07-15 |
| These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Tablets USP CII safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Tablets USP CII. Methylphenidate hydrochloride extended-release tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | KVK-Tech, Inc. | ABHAI LLC | 2024-06-20 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Accord Healthcare, Inc. | WES Pharma Inc. | 2024-06-18 |
| These highlights do not include all the information needed to use methylphenidate hydrochloride extended-release tablets USP safely and effectively. See full prescribing information for METHYLPHENIDATE hydrochloride extended-release tablets USP. METHYLPHENIDATE hydrochloride extended-release tablets USP, for oral use CII Initial U.S. Approval: 2000 | Product name | Trigen Laboratories, LLC | 2024-06-12 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HCl EXTENDED-RELEASE TABLETS. METHYLPHENIDATE HCl extended-release tablets, for oral use CII Initial U.S. Approval: 2000 | Product name | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | 2024-05-15 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION . METHYLPHENIDATE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-04-03 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE ORAL SOLUTION . METHYLPHENIDATE HYDROCHLORIDE Oral Solution, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-04-03 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE oral solution safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE oral solution. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-04-03 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-04-03 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-04-03 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-04-03 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Actavis Pharma, Inc. | 2024-04-02 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE oral solution safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE oral solution. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-04-02 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Actavis Pharma, Inc. | 2024-04-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS . METHYLPHENIDATE HYDROCHLORIDE extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | Product name | Actavis Pharma, Inc. | 2024-04-01 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 1955 | Product name | Sandoz Inc | 2024-03-29 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 2024-03-21 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. METHYLPHENIDATE HYDROCHLORIDE Extended-Release Capsules for oral use, CII Initial U.S. Approval: 1955 | Product name | Sandoz Inc | 2024-02-28 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE TABLETS. METHYLPHENIDATE HYDROCHLORIDE tablets, for oral use, CII Initial U.S. Approval: 1955 | Product name | Nivagen Pharmaceuticals, Inc. | 2024-02-26 |
| Methylphenidate HCl Chewable Tablet, CII Rx only | Product name | Bryant Ranch Prepack | 2024-02-05 |
| These highlights do not include all the information needed to use METHYLPHENIDATE HYDROCHLORIDE oral solution safely and effectively. See full prescribing information for METHYLPHENIDATE HYDROCHLORIDE oral solution. METHYLPHENIDATE HYDROCHLORIDE oral solution, CII Initial U.S. Approval: 1955 | Product name | Bryant Ranch Prepack | 2024-02-05 |